Q1 Earnings Estimate for DAWN Issued By Wedbush
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Wedbush issued their Q1 2026 earnings estimates for shares of Day One Biopharmaceuticals in a research note issued on Wednesday, May 7th. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.31) per share for the quarter. Wedbush currently has a “Outperform” rating […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Wedbush issued their Q1 2026 earnings estimates for shares of Day One Biopharmaceuticals in a research note issued on Wednesday, May 7th. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.31) per share for the quarter. Wedbush currently has a “Outperform” rating […]
